Invention Grant
- Patent Title: Hyaluronic acid-based nanoparticles as biosensors for imaging-guided surgery and drug delivery vehicles and methods associated therewith
-
Application No.: US15326694Application Date: 2015-07-18
-
Publication No.: US11617804B2Publication Date: 2023-04-04
- Inventor: Aaron Michael Mohs , Tanner Kinkade Hill , Sneha Sanjay Kelkar , Steve Kridel
- Applicant: Wake Forest University
- Applicant Address: US NC Winston-Salem
- Assignee: Wake Forest University
- Current Assignee: Wake Forest University
- Current Assignee Address: US NC Winston-Salem
- Agency: Fox Rothschild LLP
- International Application: PCT/US2015/041041 WO 20150718
- International Announcement: WO2016/011436 WO 20160121
- Main IPC: A61K49/00
- IPC: A61K49/00 ; G01N33/574 ; G01N33/58 ; G01N33/543 ; A61B5/00 ; A61B10/00 ; A61K31/337 ; B82Y5/00

Abstract:
The present invention relates to intraoperative fluorescent imaging (IFI) used both pre-clinically using in-vivo models, as well as clinically to map sentinel lymph nodes in breast cancer, skin cancer, GI cancer, lung cancer, prostate cancer and several other cancers. IFI can be used to image solid tumors both non-specifically in hepatobiliary and breast cancers as well as in prostate and ovarian cancer. In one embodiment, two-dimensional resolution to 10 μm2 is possible with optical imaging, significantly higher than other imaging modalities.
In one embodiment, the present invention relates to a series of self-assembled nanoparticles using HLA (hyaluronic acid) as both a polymeric backbone as well as targeting ligand. In some embodiments, the present invention relates to the synthesis of HLA conjugates, and the effect of variation of the hydrophobic ligand structure and conjugation level on nanoparticle self-assembly, size, ICG loading efficiency, and ICG fluorescence quenching and reactivation.
In one embodiment, the present invention relates to a series of self-assembled nanoparticles using HLA (hyaluronic acid) as both a polymeric backbone as well as targeting ligand. In some embodiments, the present invention relates to the synthesis of HLA conjugates, and the effect of variation of the hydrophobic ligand structure and conjugation level on nanoparticle self-assembly, size, ICG loading efficiency, and ICG fluorescence quenching and reactivation.
Public/Granted literature
Information query